Involvement of chymase-mediated angiotensin II generation in blood pressure regulation
Open accessThe DOI matches its Crossref record.
Abstract
Angiotensin I-converting enzyme (ACE) inhibitors are thought to lower blood pressure in hypertensive patients, mainly by decreasing angiotensin II (Ang II) formation.Chymase, a human mast cell protease, has recently been proposed to play a role in blood pressure regulation because of its Ang II-forming activity.Here we show that the predominant chymase mRNA species in the mouse aorta are those for types 4 and 5 isoforms, and that both are efficient Ang II-forming enzymes.Evaluation of ACE-dependent and ACE-independent Ang II-forming pathways in mast cell-deficient (Kit w /Kit w-v ) mice and their mast cell-sufficient littermate (MC +/+ ) controls revealed that, in contrast to the latter, Kit w /Kit w-v mice fail to express chymase mRNAs in the vasculature and have almost no ACE-independent Ang II-forming activity in either isolated blood vessels or homogenates.Moreover, in MC +/+ but not in Kit w /Kit w-v mice, a contribution of ACE-independent Ang II generation to blood pressure regulation was evident by a 1.6-fold greater maximal reduction in mean arterial pressure with acute ACE inhibition plus AT 1 receptor blockade than with ACE inhibition alone.Thus, mast cells are the source of the vascular ACE-independent pathway, and the antihypertensive benefit of combining ACE inhibitor therapy with AT 1 receptor antagonist therapy is most likely due to negation of chymase-catalyzed Ang II generation.Nonstandard abbreviations used: angiotensin I (Ang I); Ang I-converting enzyme (ACE); angiotensin II (Ang II); mouse mast cell protease (MMCP); physiological salt solution (PSS); suprarenal aortic constriction (SAC); turnover number (kcat). Conflict of interest:The authors have declared that no conflict of interest exists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure
Patel, V. B., Zhong, J.-C., Grant, M. B., & Oudit, G. Y. (2016) · Circulation Research · doi:10.1161/circresaha.116.307708 · Cited by 833
The pathophysiology of anaphylaxis
Reber, L. L., Hernandez, J. D., & Galli, S. J. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.06.003 · Cited by 507
Mast cell tryptases and chymases in inflammation and host defense.
Caughey, G. H. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00509.x · Cited by 442
“The body of experimental evidence that chymases are important in cardiovascular diseases, including regulation of blood pressure (121), is large and expanding.”
BackgroundAngiotensin receptors: a new role in cancer?
Deshayes, F., & Nahmias, C. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.07.009 · Cited by 437
The renin-angiotensin system: going beyond the classical paradigms
Santos, R. A. S., Oudit, G. Y., Verano-Braga, T., Canta, G., Steckelings, U. M., & Bader, M. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00723.2018 · Cited by 340
Singh, V. P., Le, B., Khode, R., Baker, K. M., & Kumar, R. (2008) · Diabetes · doi:10.2337/db08-0805 · Cited by 332
Pejler, G., Åbrink, M., Ringvall, M., & Wernersson, S. (2007) · Advances in Immunology · doi:10.1016/s0065-2776(07)95006-3 · Cited by 320
Mast cells in the promotion and limitation of chronic inflammation
Metz, M., Grimbaldeston, M. A., Nakae, S., Piliponsky, A. M., Tsai, M., & Galli, S. J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00520.x · Cited by 302
Mast Cells in Cardiac Fibrosis: New Insights Suggest Opportunities for Intervention
Legere, S. A., Haidl, I. D., Légaré, J.-F., & Marshall, J. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00580 · Cited by 92
Metadata
- Authors
- Li, M., Liu, K., Michalicek, J., Angus, J. A., Hunt, J. E., Dell’Italia, L. J., Feneley, M. P., Graham, R. M., & Husain, A.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-07-01
- Volume
- 114
- Issue
- 1
- Pages
- 112-120
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2022229474
- Cited by
- 113
- References
- 0
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.